Have a personal or library account? Click to login
Netherton Syndrome: A Comprehensive Literature Review of Pathogenesis, Clinical Manifestations, and Therapeutic Strategies Cover

Netherton Syndrome: A Comprehensive Literature Review of Pathogenesis, Clinical Manifestations, and Therapeutic Strategies

Journal of Mother and Child
Volume 29 (2025): Issue 1 (February 2025)
By: Martyna MocarskaORCID,  Adrianna MuciekORCID,  Julia DolinkiewiczORCID,  Anna Maria MaryńczakORCID,  Nicole NitschkeORCID,  Katarzyna StrakowskaORCID,  Laura OpalskaORCID and  Anna Maria OrłowskaORCID  
Open Access
|Sep 2025

References

  1. Comèl M. Ichthyosis linearis circumflexa. Dermatology. 1949;98(3):133–6.
    Search in Google ScholarBack to article
  2. Netherton EW. A unique case of trichorrhexis nodosa—”bamboo hairs.” Arch Dermatol. 1958 Oct 1;78(4):483–7. doi: 10.1001/archderm.1958.01560100059009.
    Open DOISearch in Google ScholarBack to article
  3. Sun JD, Linden KG. Netherton syndrome: a case report and review of the literature. Int J Dermatol. 2006 Jun 20;45(6):693–7. doi: 10.1111/j.1365-4632.2005.02637.x.
    Open DOISearch in Google ScholarBack to article
  4. Sarri CA, Roussaki-Schulze A, Vasilopoulos Y, Zafiriou E, Patsatsi A, Stamatis C, et al. Netherton syndrome: A genotype-phenotype review. Mol Diagn Ther. 2017 Apr 30;21(2):137–52. doi: 10.1007/s40291-016-0243-y.
    Open DOISearch in Google ScholarBack to article
  5. Barbati F, Giovannini M, Oranges T, Lodi L, Barni S, Novembre E, et al. Netherton syndrome in children: management and future perspectives. Front Pediatr. 2021;9:645259. doi: 10.3389/fped.2021.645259.
    Open DOISearch in Google ScholarBack to article
  6. Herz-Ruelas ME, Chavez-Alvarez S, Garza-Chapa JI, Ocampo-Candiani J, Cab-Morales VA, Kubelis-López DE. Netherton syndrome: case report and review of the literature. Skin Appendage Disord. 2021 Aug;7(5):346–50. doi: 10.1159/000514699.
    Open DOISearch in Google ScholarBack to article
  7. Sprecher E, Amin S, Nielsen K, Pfendner E, Uitto J, Richard G, et al. The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: Implications for mutation detection and first case of prenatal diagnosis. J. Invest. Dermatol. 2001 Aug;117(2):179–87. doi: 10.1046/j.1523-1747.2001.01389.x.
    Open DOISearch in Google ScholarBack to article
  8. Pontone M, Giovannini M, Filippeschi C, Oranges T, Pedaci FA, Mori F, et al. Biological treatments for pediatric Netherton syndrome. Front Pediatr. 2022 Dec 23;10:1074243. doi: 10.3389/fped.2022.1074243.
    Open DOISearch in Google ScholarBack to article
  9. Kostova P, Petrova G, Shahid M, Papochieva V, Miteva D, Yordanova I, et al. Netherton syndrome – A therapeutic challenge in childhood. Clin Case Rep. 2024 Apr 16;12(4):e8770. doi: 10.1002/ccr3.8770.
    Open DOISearch in Google ScholarBack to article
  10. Stuvel K, Heeringa JJ, Dalm VASH, Meijers RWJ, van Hoffen E, Gerritsen SAM, et al. Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency. Allergy. 2020 Jul 21;75(7):1710–20. doi: 10.1111/all.14197.
    Open DOISearch in Google ScholarBack to article
  11. SPINK5. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. https://www.hgmd.cf.ac.uk/ac/gene.php?gene=SPINK5. 2025.
    Search in Google ScholarBack to article
  12. Xu M, Shi Y, Lin L, Wang L, Zhu X, Xiong J, et al. The role of SPINK5 mutation distribution in phenotypes of Netherton syndrome. Front Genet. 2025 Jan 27;16:1475054. doi: 10.3389/fgene.2025.1475054.
    Open DOISearch in Google ScholarBack to article
  13. Barbieux C, Bonnet des Claustres M, Fahrner M, Petrova E, Tsoi LC, Gouin O, et al. Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses. J. Allergy Clin. Immunol. 2022 Apr;149(4):1358–72. doi: 10.1016/j.jaci.2021.08.024.
    Open DOISearch in Google ScholarBack to article
  14. Błażewicz I, Rustowska A, Wilkowska A, Nowicki RJ. Comèl-Netherton syndrome – case report. Przegl Dermatol. 2014;101:481–6. doi: 10.5114/dr.2014.46950
    Open DOISearch in Google ScholarBack to article
  15. Smith DL, Smith JG, Wong SW, deShazo RD. Netherton’s syndrome: A syndrome of elevated IgE and characteristic skin and hair findings. J. Allergy Clin. Immunol. 1995 Jan;95(1):116–23. doi: 10.1016/S0091-6749(95)70159-1
    Open DOISearch in Google ScholarBack to article
  16. Bittencourt M de JS, Moure ERD, Pies OTC, Mendes AD, Deprá MM, Mello ALP de. Trichoscopy as a diagnostic tool in trichorrhexis invaginata and Netherton syndrome. An Bras Dermatol. 2015 Feb;90(1):114–6. doi: 10.1590/abd1806-4841.20153011
    Open DOISearch in Google ScholarBack to article
  17. Geyer AS, Ratajczak P, Pol-Rodriguez M, Millar WS, Garzon M, Richard G. Netherton syndrome with extensive skin peeling and failure to thrive due to a homozygous frameshift mutation in SPINK5. Dermatology. 2005;210(4):308–14. doi: 10.1159/000084755.
    Open DOISearch in Google ScholarBack to article
  18. Mazereeuw-Hautier J, Paller AS, O’Toole E, Dreyfus I, Bodemer C, Akiyama M, et al. Management of congenital ichthyoses: guidelines of care: Part two: 2024 update. Br J Dermatol. 2025 Jun 20;193(1):28–43. doi: 10.1093/bjd/ljaf077.
    Open DOISearch in Google ScholarBack to article
  19. Lucker GP, van de Kerkhof PC, van Dïjk MR, Steijlen PM. Effect of topical calcipotriol on congenital ichthyoses. Br J Dermatol. 1994 Oct;131(4):546–50. doi: 10.1111/j.1365-2133.1994.tb08558.x.
    Open DOISearch in Google ScholarBack to article
  20. Luchsinger I, Knöpfel N, Theiler M, Bonnet des Claustres M, Barbieux C, Schwieger-Briel A, et al. Secukinumab therapy for Netherton syndrome. JAMA Dermatol. 2020 Aug 1;156(8):907–11. doi: 10.1001/jamadermatol.2020.1019
    Open DOISearch in Google ScholarBack to article
  21. Volc S, Maier L, Gritsch A, Aichelburg MC, Volc-Platzer B. Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl. British Journal of Dermatology. 2020 Jul 9;183(1):165–7. doi: 10.1111/bjd.18892.
    Open DOISearch in Google ScholarBack to article
  22. Yalcin AD. A case of Netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels. Immunopharmacol Immunotoxicol. 2016 Mar 3;38(2):162–6. doi: 10.3109/08923973.2015.1115518.
    Open DOISearch in Google ScholarBack to article
  23. Süßmuth K, Traupe H, Loser K, Ständer S, Kessel C, Wittkowski H, et al. Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e152–5. doi: 10.1111/jdv.16883.
    Open DOISearch in Google ScholarBack to article
  24. Murase C, Takeichi T, Taki T, Yoshikawa T, Suzuki A, Ogi T, et al. Successful dupilumab treatment for ichthyotic and atopic features of Netherton syndrome. J Dermatol Sci. 2021 May;102(2):126–9. doi: 10.1016/j.jdermsci.2021.03.003.
    Open DOISearch in Google ScholarBack to article
  25. Andreasen TH, Karstensen HG, Duno M, Lei U, Zachariae C, Thyssen JP. Successful treatment with dupilumab of an adult with Netherton syndrome. Clin Exp Dermatol. 2020 Oct;45(7):915–7. doi: 10.1111/ced.14317.
    Open DOISearch in Google ScholarBack to article
  26. Mazereeuw-Hautier J, Paller AS, Dreyfus I, Sprecher E, O’Toole E, Bodemer C, et al. Management of congenital ichthyoses: Guidelines of care: Part one: 2024 update. Br J Dermatol. 2025 Jun 20;193(1):16–27. doi: 10.1093/bjd/ljaf076.
    Open DOISearch in Google ScholarBack to article
  27. Liddle J, Beneton V, Benson M, Bingham R, Bouillot A, Boullay AB, et al. A potent and selective kallikrein-5 inhibitor delivers high pharmacological activity in skin from patients with Netherton syndrome. J Invest Dermatol. 2021 Sep;141(9):2272–9. doi: 10.1016/j.jid.2021.01.029
    Open DOISearch in Google ScholarBack to article
  28. Zingkou E, Pampalakis G, Sotiropoulou G. Cathelicidin represents a new target for manipulation of skin inflammation in Netherton syndrome. Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165831. doi: 10.1016/j.bbadis.2020.165831.
    Open DOISearch in Google ScholarBack to article
  29. Di WL, Lwin SM, Petrova A, Bernadis C, Syed F, Farzaneh F, et al. Generation and clinical application of gene-modified autologous epidermal sheets in Netherton syndrome: Lessons learned from a Phase 1 trial. Hum Gene Ther. 2019 Sep 1;30(9):1067–78. doi: 10.1089/hum.2019.049
    Open DOISearch in Google ScholarBack to article
  30. Salehi M, Neshati Z, Ahanchian H, Tafrishi R, Pasdar A, Safi M, et al. Hyper IgE syndromes: understanding, management, and future perspectives: a narrative review. Health Sci Rep. 2025 Mar 19;8(3). doi: 10.1002/hsr2.70497
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.34763/jmotherandchild.20252901.d-25-00014 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488
Journal RSS Feed
Language: English
Page range: 106 - 113
Submitted on: May 29, 2025
Accepted on: Aug 14, 2025
Published on: Sep 2, 2025
Published by: Institute of Mother and Child
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Atopic dermatitis,
Netherton syndrome,
trichorrhexis invaginata,
bamboo hair,
SPINK5 gene
Related subjects:
Medicine,
Clinical medicine,
Pediatrics and juvenile medicine,
Paediatric haematology and oncology,
Public health

© 2025 Martyna Mocarska, Adrianna Muciek, Julia Dolinkiewicz, Anna Maria Maryńczak, Nicole Nitschke, Katarzyna Strakowska, Laura Opalska, Anna Maria Orłowska, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 29 (2025): Issue 1 (February 2025)Next article